Alambic Investment Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,198
Closed -$577K 409
2019
Q1
$577K Sell
3,198
-2,225
-41% -$322K 0.24% 152
2018
Q4
$602K Buy
5,423
+4,016
+285% +$523K 0.25% 146
2018
Q3
$190K Sell
1,407
-1,260
-47% -$174K 0.15% 219
2018
Q2
$368K Sell
2,667
-1,865
-41% -$257K 0.1% 245
2018
Q1
$625K Buy
4,532
+2,587
+133% +$352K 0.09% 291
2017
Q4
$239K Buy
1,945
+1,603
+469% +$220K 0.03% 394
2017
Q3
$47K Buy
+342
New +$51.6K 0.01% 479
2017
Q1
Sell
-477
Closed -$46K 693
2016
Q4
$46K Sell
477
-106
-18% -$9.72K 0.01% 555
2016
Q3
$55K Buy
+583
New +$58.4K 0.01% 495

Other funds holding SRGA

Alambic Investment Management's SRGA Position: Q2 2019 in Review

Alambic Investment Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2019, closing a stake of 3,198 shares — an estimated $577K sold.

Alambic Investment Management first reported a position in SRGA in Q3 2016 and held it in 9 quarters. The position peaked at $625K in Q1 2018. 106 funds tracked by Wall St. Rank hold SRGA as of Q2 2019.

  • Alambic Investment Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Alambic Investment Management sold 3,198 Surgalign Holdings, Inc. Common Stock shares in Q2 2019, an estimated $577K.
  • Alambic Investment Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2016 and held it in 9 quarters.
  • Alambic Investment Management's Surgalign Holdings, Inc. Common Stock position peaked at $625K in Q1 2018.
  • 106 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2019.

Based on Alambic Investment Management's 13F filing for Q2 2019, filed 13 Aug 2019.